Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | SLXN stock touches 52-week low at $0.82 amid market challenges | 1 | Investing.com | ||
10.09. | Pre-market Movers: Silexion Therapeutics, Quoin Pharmaceuticals, Actelis Networks, Mission Produce, Singularity Future Technology | 563 | AFX News | REDWOOD SHORES (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.15 A.M. ET).In the Green Silexion Therapeutics Corp (SLXN) is up over... ► Artikel lesen | |
09.09. | Silexion Therapeutics Corp - 8-K, Current Report | 2 | SEC Filings | ||
09.09. | PESG Research: PESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven Cancers | 187 | Business Wire | Report covers Silexion Therapeutics (NASDAQ: SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company's... ► Artikel lesen | |
03.09. | Silexion Therapeutics, Inc.: Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference | 1 | GlobeNewswire (USA) | ||
29.08. | Silexion Therapeutics Corp - 10-Q, Quarterly Report | 1 | SEC Filings | ||
21.08. | Silexion Therapeutics Corp - 8-K, Current Report | 1 | SEC Filings | ||
16.08. | SLXN stock touches 52-week low at $4.57 amid market shifts | 1 | Investing.com | ||
15.08. | Silexion Therapeutics and Moringa Acquisition Corp Announce Closing of their Business Combination | 237 | GlobeNewswire (Europe) | MODI'IN, Israel and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Silexion Therapeutics Ltd. ("Silexion"), a clinical-stage, oncology-focused biotechnology company and Moringa Acquisition Corp (Nasdaq:... ► Artikel lesen | |
13.08. | Moringa Acquisition Corp Shareholders Approve Silexion Merger | 1 | Investing.com | ||
22.02. | Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp | 99 | GlobeNewswire (Europe) | Silexion's first generation product, Loder, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PORTAGE BIOTECH | 9,850 | 0,00 % | Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at... ► Artikel lesen | |
QIAGEN | 41,190 | -0,95 % | Biotech Report: Biontech ziehen an, Qiagen erneut leichter | (shareribs.com) Frankfurt / New York 12.09.2024 - Biotech-Aktien tendierten im deutschen Handel überwiegend schwächer. Biontech und 4SC konnten zulegen. An der Wall Street konnte der Sektor derweil... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 24,550 | 0,00 % | ROUNDUP/Aktien New York: Neue Rekorde vor US-Zinsentscheid | NEW YORK (dpa-AFX) - Vor dem Zinsentscheid der US-Notenbank Fed bleiben die Anleger an den New Yorker Börsen optimistisch. Der Leitindex Dow Jones Industrial markierte am Dienstag gleich zu Beginn... ► Artikel lesen | |
ADMA BIOLOGICS | 19,300 | +3,15 % | ADMA Biologics, Inc.: ADMA Biologics Set to Join S&P SmallCap 600 Index | RAMSEY, N.J. and BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing... ► Artikel lesen | |
AVIDITY BIOSCIENCES | 44,620 | 0,00 % | Unveiling 7 Analyst Insights On Avidity Biosciences | ||
EVOTEC | 6,460 | -0,39 % | Evotec Aktie: Gelingt eine Überraschung wie bei HelloFresh? | Es könnte spannend werden bei der Evotec Aktie, bei der zuletzt einige "Insiderkäufe" zu sehen waren, zugleich Shortseller sehr aktiv sind. In einer ähnlichen Konstellation sorgte gestern bei HelloFresh... ► Artikel lesen | |
MOONLAKE IMMUNOTHERAPEUTICS | 53,21 | 0,00 % | H.C. Wainwright bekräftigt Kaufempfehlung für Moonlake Immunotherapeutics-Aktie | ||
EDGEWISE THERAPEUTICS | 19,040 | 0,00 % | Edgewise präsentiert Daten aus Phase-1- und -2-Studien für Herzmedikament | ||
NUVALENT | 102,76 | 0,00 % | Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally? | ||
ARRIVENT BIOPHARMA | 23,580 | -1,50 % | ArriVent BioPharma, Inc.: ArriVent BioPharma Reports Second Quarter 2024 Financial Results | Clinical proof-of-concept monotherapy data for once daily, first-line firmonertinib in EGFR PACC mutant non-small cell lung cancer (NSCLC) to be presented as a presidential symposium presentation... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 6,900 | 0,00 % | Angle PLC Announces Agreement with Recursion Pharmaceuticals | New pharma agreement for Parsortix CTC analysisGUILDFORD, SURREY / ACCESSWIRE / September 19, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating... ► Artikel lesen | |
ARCELLX | 80,55 | 0,00 % | ACLX, HROW Deliver Triple-Digit Returns - Did You Cash In? | WASHINGTON (dpa-AFX) - Many traders seek instant gratification in the stock market. Some stocks offer quick profits, while others require a patient, long-term approach for significant returns.... ► Artikel lesen | |
LONGBOARD PHARMACEUTICALS | 29,310 | +6,27 % | Baird maintains Outperform rating on Longboard Pharmaceuticals stock with steady price target | ||
IMMUNOVANT | 28,990 | -0,31 % | Immunovant stock maintains Overweight rating from Piper Sandler | ||
INSTIL BIO | 66,11 | 0,00 % | Instil Bio: Waschechter Tenbagger für den NBC! | Die Erfolgsgeschichte des exklusiven No Brainer Clubs (NBC) setzt sich fort: Mit Instil Bio hat der NBC erneut einen absoluten Volltreffer gelandet, der Mitgliedern je nach Einstiegszeitpunkt +736 bis... ► Artikel lesen |